HIV/AIDS Therapy
Merck reduces price of Stocrin in least-developed countries
Published in AIDS Weekly, April 3rd, 2006
The price of the 600 mg formulation of Stocrin has been reduced by 20% to US$0.76 per day, or US$277.40 per patient per year, from $0.95 per day. The 200 mg formulation of Stocrin has been reduced by 22% to US$0.36 per capsule, or $1.08 per day and about US$394.20 per patient per year, from $0.46 per capsule. Merck is lowering the price of these formulations of Stocrin due to new efficiencies and cost savings resulting from improved manufacturing processes.
At the end of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2006-04-03)
More Articles from AIDS Weekly
- HIV/AIDS Epidemiology
HIV-1 non-B subtype transmission continues in the U.K. - HIV/AIDS Genetics & Genomics
HIV disease progression rate influenced by HLA-B locus polymorphism - HIV/AIDS HAART
HIV-1 RNA helps guide patient selection for HAART in resource-poor settings - HIV/AIDS Seroreversion
HIV antibody seroreversion does not indicate viral eradication - Proteomics
Interferon-alpha mediates anti-HIV activity via APOBEC3G induction - Adverse Drug Reaction
KS aggravated by rituximab when used to treat HIV-related multicentric Castleman disease - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
